Tag: MEDYTOX
-
Delays Hit Korean Botulinum Toxin Companies in Chinese Market Entry
Korean botulinum toxin firms are experiencing delays in penetrating the competitive Chinese market due to increased regulatory scrutiny and intensified competition. Companies such as I-Maker Technology and Daewoong Pharmaceutical have postponed their launches, while new entrants are changing market dynamics. Amid this backdrop, the Chinese market is projected to reach $1.55 billion by 2025, highlighting…